{
  "analysis_mode": "HISTORICAL_ONLY",
  "report_version": "5.0",
  "symbol": "GDR.L",
  "generated_at": "2026-02-06T17:03:57.607676+00:00",
  "comprehensive_apex": {
    "score": 29,
    "rating": "LOW QUALITY",
    "color": "#ef4444",
    "calculation": "(53\u00d725% + 40\u00d720% + 59.2\u00d730% + 35\u00d725%) \u00d7 0.6 = 29",
    "components": {
      "setup": {
        "score": 53,
        "weight": 0.25
      },
      "trust": {
        "score": 40,
        "weight": 0.2
      },
      "panic": {
        "score": 59.2,
        "weight": 0.3
      },
      "compression": {
        "score": 35,
        "weight": 0.25
      }
    },
    "timing": {
      "regime": "CROWDED",
      "multiplier": 0.6
    }
  },
  "top_card": {
    "ticker": "GDR.L",
    "company_name": "genedrive plc",
    "sector": "Healthcare",
    "market_cap_gbp": 11737485,
    "days_active": 122,
    "apex_score_100": 53,
    "confidence_score_100": 40,
    "panic_score_100": 59.2,
    "cc_score_100": 35,
    "ai_final_score_25": 12,
    "ai_strength": "MODERATE",
    "timing_regime": "CROWDED",
    "action": "SELL/TAKE_PROFITS",
    "thesis_one_liner": "SELL/TAKE_PROFITS - CROWDED timing with 53/100 opportunity score",
    "overall_score_100": 47
  },
  "enrichment": {
    "company_info": {
      "name": "genedrive plc",
      "sector": "Healthcare",
      "industry": "Diagnostics & Research",
      "exchange": "LSE",
      "market": "AIM",
      "currency": "GBP",
      "risk_tier": "High Risk",
      "current_market_cap": 11737485,
      "current_close_price": 1.14
    },
    "basics": {
      "ticker": "GDR.L",
      "current_price": 1.14,
      "ath": 302.601,
      "atl": 0.19,
      "ath_date": "2020-05-05",
      "atl_date": "2025-09-24",
      "week_52_high": 2.25,
      "week_52_low": 0.19,
      "week_52_high_date": "2025-02-06",
      "week_52_low_date": "2025-09-24",
      "drawdown_from_ath_pct": 99.62,
      "data_start": "2020-01-02",
      "data_end": "2026-02-06",
      "total_bars": 1541
    },
    "latest_signal": {
      "date": "2025-10-07",
      "scan_date": "2026-01-26",
      "signal_type": "DEEP CRASH BOTTOM",
      "signal_color": "GREEN",
      "price": 0.255,
      "drawdown_pct": 91.5,
      "ai_score": 10.0,
      "rsi": 21.0,
      "cycle_position": 0.057,
      "holding_period_days": 122,
      "current_pnl_pct": 347.06,
      "rally_state": "rallying",
      "distance_from_high_pct": -7.74,
      "Rally_Count": 1,
      "days_since_last_high": 21,
      "last_high_date": "2026-01-05",
      "lock_in_reached": true,
      "lock_in_date": "2026-01-20",
      "best_rally_pct": 360.78
    },
    "best_historical_signal": {
      "signal_date": "2025-09-25",
      "signal_type": "CRASH ZONE BOTTOM",
      "signal_color": "YELLOW",
      "entry_price": 0.23,
      "peak_price": 1.25,
      "peak_date": "2026-01-20",
      "rally_pct": 443.48,
      "days_to_peak": 117,
      "ai_score": 11.0
    },
    "all_historical_signals": [
      {
        "signal_id": "GDR.L_2021-01-08",
        "signal_date": "2021-01-08",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 43.0,
        "current_price": 1.084,
        "current_return_pct": -97.48,
        "best_rally_pct": 246.51,
        "best_rally_date": "2021-03-12",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -99.27,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 1844,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2021-01-14",
        "signal_date": "2021-01-14",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 42.5,
        "current_price": 1.084,
        "current_return_pct": -97.45,
        "best_rally_pct": 250.59,
        "best_rally_date": "2021-03-12",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -99.27,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 1838,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2021-01-18",
        "signal_date": "2021-01-18",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 42.0,
        "current_price": 1.084,
        "current_return_pct": -97.42,
        "best_rally_pct": 254.76,
        "best_rally_date": "2021-03-12",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -99.27,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 1834,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2021-09-10",
        "signal_date": "2021-09-10",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 28.5,
        "current_price": 1.084,
        "current_return_pct": -96.2,
        "best_rally_pct": 145.61,
        "best_rally_date": "2021-12-09",
        "rally_state": "accumulating",
        "Rally_Count": 5,
        "distance_from_high_pct": -98.45,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 1599,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2021-09-14",
        "signal_date": "2021-09-14",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 26.0,
        "current_price": 1.084,
        "current_return_pct": -95.83,
        "best_rally_pct": 169.23,
        "best_rally_date": "2021-12-09",
        "rally_state": "accumulating",
        "Rally_Count": 9,
        "distance_from_high_pct": -98.45,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 1595,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2021-09-16",
        "signal_date": "2021-09-16",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 25.75,
        "current_price": 1.084,
        "current_return_pct": -95.79,
        "best_rally_pct": 171.84,
        "best_rally_date": "2021-12-09",
        "rally_state": "accumulating",
        "Rally_Count": 8,
        "distance_from_high_pct": -98.45,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 1593,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2021-09-29",
        "signal_date": "2021-09-29",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 25.0,
        "current_price": 1.084,
        "current_return_pct": -95.66,
        "best_rally_pct": 180.0,
        "best_rally_date": "2021-12-09",
        "rally_state": "accumulating",
        "Rally_Count": 6,
        "distance_from_high_pct": -98.45,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 1580,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2021-10-01",
        "signal_date": "2021-10-01",
        "signal_type": "ENHANCED DEEP CRASH-ACCUM COMBO",
        "signal_color": "PURPLE",
        "entry_price": 24.75,
        "current_price": 1.084,
        "current_return_pct": -95.62,
        "best_rally_pct": 182.83,
        "best_rally_date": "2021-12-09",
        "rally_state": "accumulating",
        "Rally_Count": 6,
        "distance_from_high_pct": -98.45,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 1578,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2021-11-08",
        "signal_date": "2021-11-08",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 19.2,
        "current_price": 1.084,
        "current_return_pct": -94.35,
        "best_rally_pct": 264.58,
        "best_rally_date": "2021-12-09",
        "rally_state": "accumulating",
        "Rally_Count": 6,
        "distance_from_high_pct": -98.45,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 1540,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2021-11-09",
        "signal_date": "2021-11-09",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 19.25,
        "current_price": 1.084,
        "current_return_pct": -94.37,
        "best_rally_pct": 263.64,
        "best_rally_date": "2021-12-09",
        "rally_state": "accumulating",
        "Rally_Count": 6,
        "distance_from_high_pct": -98.45,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 1539,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2021-11-10",
        "signal_date": "2021-11-10",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 19.25,
        "current_price": 1.084,
        "current_return_pct": -94.37,
        "best_rally_pct": 263.64,
        "best_rally_date": "2021-12-09",
        "rally_state": "accumulating",
        "Rally_Count": 6,
        "distance_from_high_pct": -98.45,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 1538,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2021-11-12",
        "signal_date": "2021-11-12",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 18.3,
        "current_price": 1.084,
        "current_return_pct": -94.08,
        "best_rally_pct": 282.51,
        "best_rally_date": "2021-12-09",
        "rally_state": "accumulating",
        "Rally_Count": 6,
        "distance_from_high_pct": -98.45,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 1536,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2021-11-25",
        "signal_date": "2021-11-25",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 17.5,
        "current_price": 1.084,
        "current_return_pct": -93.81,
        "best_rally_pct": 300.0,
        "best_rally_date": "2021-12-09",
        "rally_state": "accumulating",
        "Rally_Count": 4,
        "distance_from_high_pct": -98.45,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 1523,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2022-01-19",
        "signal_date": "2022-01-19",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 22.0,
        "current_price": 1.084,
        "current_return_pct": -95.07,
        "best_rally_pct": 95.45,
        "best_rally_date": "2023-03-17",
        "rally_state": "accumulating",
        "Rally_Count": 4,
        "distance_from_high_pct": -97.48,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 1468,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2022-08-30",
        "signal_date": "2022-08-30",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 15.5,
        "current_price": 1.084,
        "current_return_pct": -93.01,
        "best_rally_pct": 177.42,
        "best_rally_date": "2023-03-17",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -97.48,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 1245,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2022-09-07",
        "signal_date": "2022-09-07",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 13.75,
        "current_price": 1.084,
        "current_return_pct": -92.12,
        "best_rally_pct": 212.73,
        "best_rally_date": "2023-03-17",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -97.48,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 1237,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2022-09-15",
        "signal_date": "2022-09-15",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 11.75,
        "current_price": 1.084,
        "current_return_pct": -90.77,
        "best_rally_pct": 265.96,
        "best_rally_date": "2023-03-17",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -97.48,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 1229,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2022-09-16",
        "signal_date": "2022-09-16",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 12.75,
        "current_price": 1.084,
        "current_return_pct": -91.5,
        "best_rally_pct": 237.25,
        "best_rally_date": "2023-03-17",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -97.48,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 1228,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2022-09-20",
        "signal_date": "2022-09-20",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 12.5,
        "current_price": 1.084,
        "current_return_pct": -91.33,
        "best_rally_pct": 244.0,
        "best_rally_date": "2023-03-17",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -97.48,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 1224,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2022-09-23",
        "signal_date": "2022-09-23",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 11.75,
        "current_price": 1.084,
        "current_return_pct": -90.77,
        "best_rally_pct": 265.96,
        "best_rally_date": "2023-03-17",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -97.48,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 1221,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2022-09-26",
        "signal_date": "2022-09-26",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 11.75,
        "current_price": 1.084,
        "current_return_pct": -90.77,
        "best_rally_pct": 265.96,
        "best_rally_date": "2023-03-17",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -97.48,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 1218,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2022-09-28",
        "signal_date": "2022-09-28",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 11.5,
        "current_price": 1.084,
        "current_return_pct": -90.57,
        "best_rally_pct": 273.91,
        "best_rally_date": "2023-03-17",
        "rally_state": "accumulating",
        "Rally_Count": 4,
        "distance_from_high_pct": -97.48,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 1216,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2022-11-08",
        "signal_date": "2022-11-08",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 10.25,
        "current_price": 1.084,
        "current_return_pct": -89.42,
        "best_rally_pct": 319.51,
        "best_rally_date": "2023-03-17",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -97.48,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 1175,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2022-11-09",
        "signal_date": "2022-11-09",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 9.9,
        "current_price": 1.084,
        "current_return_pct": -89.05,
        "best_rally_pct": 334.34,
        "best_rally_date": "2023-03-17",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -97.48,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 1174,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2022-11-21",
        "signal_date": "2022-11-21",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 10.0,
        "current_price": 1.084,
        "current_return_pct": -89.16,
        "best_rally_pct": 330.0,
        "best_rally_date": "2023-03-17",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -97.48,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 1162,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2022-11-23",
        "signal_date": "2022-11-23",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 9.0,
        "current_price": 1.084,
        "current_return_pct": -87.96,
        "best_rally_pct": 377.78,
        "best_rally_date": "2023-03-17",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -97.48,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 1160,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2023-10-30",
        "signal_date": "2023-10-30",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 8.625,
        "current_price": 1.084,
        "current_return_pct": -87.43,
        "best_rally_pct": 10.14,
        "best_rally_date": "2023-12-05",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -88.59,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 819,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2023-11-01",
        "signal_date": "2023-11-01",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 8.4,
        "current_price": 1.084,
        "current_return_pct": -87.1,
        "best_rally_pct": 13.1,
        "best_rally_date": "2023-12-05",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -88.59,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 817,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2023-11-07",
        "signal_date": "2023-11-07",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 8.25,
        "current_price": 1.084,
        "current_return_pct": -86.86,
        "best_rally_pct": 15.15,
        "best_rally_date": "2023-12-05",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -88.59,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 811,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2023-11-28",
        "signal_date": "2023-11-28",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 7.125,
        "current_price": 1.084,
        "current_return_pct": -84.79,
        "best_rally_pct": 33.33,
        "best_rally_date": "2023-12-05",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -88.59,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 790,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2023-11-30",
        "signal_date": "2023-11-30",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 6.125,
        "current_price": 1.084,
        "current_return_pct": -82.3,
        "best_rally_pct": 55.1,
        "best_rally_date": "2023-12-05",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -88.59,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 788,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2023-12-01",
        "signal_date": "2023-12-01",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 5.75,
        "current_price": 1.084,
        "current_return_pct": -81.15,
        "best_rally_pct": 65.22,
        "best_rally_date": "2023-12-05",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -88.59,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 787,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2023-12-04",
        "signal_date": "2023-12-04",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 6.125,
        "current_price": 1.084,
        "current_return_pct": -82.3,
        "best_rally_pct": 55.1,
        "best_rally_date": "2023-12-05",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -88.59,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 784,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2024-02-09",
        "signal_date": "2024-02-09",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 5.0,
        "current_price": 1.084,
        "current_return_pct": -78.32,
        "best_rally_pct": 56.0,
        "best_rally_date": "2024-04-04",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -86.1,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 717,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2024-03-15",
        "signal_date": "2024-03-15",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 3.75,
        "current_price": 1.084,
        "current_return_pct": -71.09,
        "best_rally_pct": 108.0,
        "best_rally_date": "2024-04-04",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -86.1,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 682,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2024-03-22",
        "signal_date": "2024-03-22",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 3.75,
        "current_price": 1.084,
        "current_return_pct": -71.09,
        "best_rally_pct": 108.0,
        "best_rally_date": "2024-04-04",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -86.1,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 675,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2024-03-26",
        "signal_date": "2024-03-26",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 3.125,
        "current_price": 1.084,
        "current_return_pct": -65.31,
        "best_rally_pct": 149.6,
        "best_rally_date": "2024-04-04",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -86.1,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 671,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2024-05-03",
        "signal_date": "2024-05-03",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 4.375,
        "current_price": 1.084,
        "current_return_pct": -75.22,
        "best_rally_pct": 3.43,
        "best_rally_date": "2024-07-17",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -76.04,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 633,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2024-05-07",
        "signal_date": "2024-05-07",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 3.875,
        "current_price": 1.084,
        "current_return_pct": -72.03,
        "best_rally_pct": 16.77,
        "best_rally_date": "2024-07-17",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -76.04,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 629,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2024-05-08",
        "signal_date": "2024-05-08",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 3.5,
        "current_price": 1.084,
        "current_return_pct": -69.03,
        "best_rally_pct": 29.29,
        "best_rally_date": "2024-07-17",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -76.04,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 628,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2024-05-09",
        "signal_date": "2024-05-09",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 2.8,
        "current_price": 1.084,
        "current_return_pct": -61.29,
        "best_rally_pct": 61.61,
        "best_rally_date": "2024-07-17",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -76.04,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 627,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2024-05-10",
        "signal_date": "2024-05-10",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 1.8,
        "current_price": 1.084,
        "current_return_pct": -39.78,
        "best_rally_pct": 151.39,
        "best_rally_date": "2024-07-17",
        "rally_state": "accumulating",
        "Rally_Count": 4,
        "distance_from_high_pct": -76.04,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 626,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2024-05-13",
        "signal_date": "2024-05-13",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 2.0,
        "current_price": 1.084,
        "current_return_pct": -45.8,
        "best_rally_pct": 126.25,
        "best_rally_date": "2024-07-17",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -76.04,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 623,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2024-05-14",
        "signal_date": "2024-05-14",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 2.0,
        "current_price": 1.084,
        "current_return_pct": -45.8,
        "best_rally_pct": 126.25,
        "best_rally_date": "2024-07-17",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -76.04,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 622,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2024-05-21",
        "signal_date": "2024-05-21",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 1.675,
        "current_price": 1.084,
        "current_return_pct": -35.28,
        "best_rally_pct": 170.15,
        "best_rally_date": "2024-07-17",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -76.04,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 615,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2024-05-24",
        "signal_date": "2024-05-24",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 1.85,
        "current_price": 1.084,
        "current_return_pct": -41.41,
        "best_rally_pct": 144.59,
        "best_rally_date": "2024-07-17",
        "rally_state": "accumulating",
        "Rally_Count": 4,
        "distance_from_high_pct": -76.04,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 612,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2024-05-30",
        "signal_date": "2024-05-30",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 1.5,
        "current_price": 1.084,
        "current_return_pct": -27.73,
        "best_rally_pct": 201.67,
        "best_rally_date": "2024-07-17",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -76.04,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 606,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2024-05-31",
        "signal_date": "2024-05-31",
        "signal_type": "ENHANCED DEEP CRASH-ACCUM COMBO",
        "signal_color": "PURPLE",
        "entry_price": 1.475,
        "current_price": 1.084,
        "current_return_pct": -26.51,
        "best_rally_pct": 206.78,
        "best_rally_date": "2024-07-17",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -76.04,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 605,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2024-06-03",
        "signal_date": "2024-06-03",
        "signal_type": "ENHANCED DEEP CRASH-ACCUM COMBO",
        "signal_color": "PURPLE",
        "entry_price": 1.475,
        "current_price": 1.084,
        "current_return_pct": -26.51,
        "best_rally_pct": 206.78,
        "best_rally_date": "2024-07-17",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -76.04,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 602,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2024-06-05",
        "signal_date": "2024-06-05",
        "signal_type": "ENHANCED EXTREME CRASH-ACCUM COMBO",
        "signal_color": "PURPLE",
        "entry_price": 1.475,
        "current_price": 1.084,
        "current_return_pct": -26.51,
        "best_rally_pct": 206.78,
        "best_rally_date": "2024-07-17",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -76.04,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 600,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2024-06-06",
        "signal_date": "2024-06-06",
        "signal_type": "ENHANCED CRASH CRASH-ACCUM COMBO",
        "signal_color": "PURPLE",
        "entry_price": 1.53,
        "current_price": 1.084,
        "current_return_pct": -29.15,
        "best_rally_pct": 195.75,
        "best_rally_date": "2024-07-17",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -76.04,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 599,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2024-12-02",
        "signal_date": "2024-12-02",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 1.83,
        "current_price": 1.084,
        "current_return_pct": -40.77,
        "best_rally_pct": 36.61,
        "best_rally_date": "2024-12-23",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -56.64,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 420,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2025-02-21",
        "signal_date": "2025-02-21",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 2.0,
        "current_price": 1.084,
        "current_return_pct": -45.8,
        "best_rally_pct": 5.0,
        "best_rally_date": "2025-03-10",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -48.38,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 339,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2025-03-27",
        "signal_date": "2025-03-27",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1.525,
        "current_price": 1.084,
        "current_return_pct": -28.92,
        "best_rally_pct": 2.95,
        "best_rally_date": "2025-03-28",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -30.96,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 305,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2025-03-28",
        "signal_date": "2025-03-28",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1.57,
        "current_price": 1.084,
        "current_return_pct": -30.96,
        "best_rally_pct": -0.64,
        "best_rally_date": "2025-04-15",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 304,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2025-03-31",
        "signal_date": "2025-03-31",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1.53,
        "current_price": 1.084,
        "current_return_pct": -29.15,
        "best_rally_pct": 1.96,
        "best_rally_date": "2025-04-15",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -30.51,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 301,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2025-09-05",
        "signal_date": "2025-09-05",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.425,
        "current_price": 1.084,
        "current_return_pct": 155.06,
        "best_rally_pct": 176.47,
        "best_rally_date": "2026-01-20",
        "rally_state": "rallying",
        "Rally_Count": 2,
        "distance_from_high_pct": -7.74,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 143,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2025-09-08",
        "signal_date": "2025-09-08",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.425,
        "current_price": 1.084,
        "current_return_pct": 155.06,
        "best_rally_pct": 176.47,
        "best_rally_date": "2026-01-20",
        "rally_state": "rallying",
        "Rally_Count": 2,
        "distance_from_high_pct": -7.74,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 140,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2025-09-24",
        "signal_date": "2025-09-24",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 0.255,
        "current_price": 1.084,
        "current_return_pct": 325.1,
        "best_rally_pct": 360.78,
        "best_rally_date": "2026-01-20",
        "rally_state": "rallying",
        "Rally_Count": 1,
        "distance_from_high_pct": -7.74,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 124,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2025-09-25",
        "signal_date": "2025-09-25",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 0.23,
        "current_price": 1.084,
        "current_return_pct": 371.3,
        "best_rally_pct": 410.87,
        "best_rally_date": "2026-01-20",
        "rally_state": "rallying",
        "Rally_Count": 1,
        "distance_from_high_pct": -7.74,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 123,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2025-09-29",
        "signal_date": "2025-09-29",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.25,
        "current_price": 1.084,
        "current_return_pct": 333.6,
        "best_rally_pct": 370.0,
        "best_rally_date": "2026-01-20",
        "rally_state": "rallying",
        "Rally_Count": 1,
        "distance_from_high_pct": -7.74,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 119,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2025-09-30",
        "signal_date": "2025-09-30",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.24,
        "current_price": 1.084,
        "current_return_pct": 351.67,
        "best_rally_pct": 389.58,
        "best_rally_date": "2026-01-20",
        "rally_state": "rallying",
        "Rally_Count": 1,
        "distance_from_high_pct": -7.74,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 118,
        "status": "historical"
      },
      {
        "signal_id": "GDR.L_2025-10-07",
        "signal_date": "2025-10-07",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.255,
        "current_price": 1.084,
        "current_return_pct": 325.1,
        "best_rally_pct": 360.78,
        "best_rally_date": "2026-01-20",
        "rally_state": "rallying",
        "Rally_Count": 1,
        "distance_from_high_pct": -7.74,
        "days_since_last_high": 21,
        "lock_in_reached": true,
        "age_days": 111,
        "status": "historical"
      }
    ],
    "stats": {
      "total_signals": 63,
      "win_rate_pct": 100.0,
      "avg_rally_pct": 221.61,
      "median_rally_pct": 228.0,
      "best_rally_pct": 443.48,
      "worst_rally_pct": 10.0
    },
    "splits": [],
    "split_risk": {
      "split_detected": false,
      "risk_level": "NONE",
      "confidence": "HIGH"
    },
    "data_quality": {
      "price_reliability": "RELIABLE",
      "pnl_reliability": "RELIABLE",
      "overall_confidence": "HIGH"
    },
    "risk_flags": [
      "EXTREME_DRAWDOWN",
      "FREQUENT_CRASHES"
    ],
    "last_updated": "2026-02-06 14:05:19 UTC",
    "volatility": {
      "atr_normalized": 7.9,
      "stddev_20d": 0.0
    },
    "trends": {
      "intelligence_signal": "UPTREND"
    }
  },
  "decision_summary": {
    "why_it_matters": [
      "APEX 53/100 indicates strong opportunity quality",
      "Timing regime: CROWDED",
      "Historical profile: 1 rallies, 361% best run"
    ],
    "main_risk": "Confidence 40/100 - full data loaded",
    "watch_next": [
      "RNS catalysts (funding/operational updates)",
      "Volume expansion confirmation",
      "Timing regime change signals"
    ]
  },
  "triangulation": {
    "rns": {
      "has_data": true,
      "ticker": "GDR.L",
      "latest": [
        {
          "title": "Holding(s) in Company",
          "date": "27th Jan 2026",
          "announcement_date": "27th Jan 2026",
          "release_time": "2:18 pm",
          "source": "RNS",
          "content": "27 Jan 2026 14:18\nRNS Number : 5901Q\nGenedrive PLC\n27 January 2026\nTR-1: S\ntandard form for notification of major holdings\nNOTIFICATION OF MAJOR HOLDINGS\n(to be sent to the relevant issuer\nand\nto the FCA in Microsoft Word format if possible)\ni\n1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached\nii\n:\nGenedrive PLC\n1b. Please indicate if the issuer is a non-UK issuer\n(please mark with an \"X\" if appropriate)\nNon-UK issuer\n2. Reason for the notification\n(please mark the appropriate box or boxes with an \"X\")\nAn acquisition or disposal of voting rights\nX\nAn acquisition or disposal of financial instruments\nAn event changing the breakdown of voting rights\nOther (please specify) iii:\n3. Details of person subject to the notification obligation\niv\nName\nMr David Nugent\nCity and country of registered office (if applicable)\n4. Full name of shareholder(s)\n(if different from 3.)\nv\nName\nCity and country of registered office (if applicable)\n5. Date on which the threshold was crossed or reached\nvi\n:\n23-01-2026\n6.\nDate on which issuer notified (DD/MM/YYYY):\n27-01-2026\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8. A)\n% of\nvoting rights through\nfinancial instruments(total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer (8.A + 8.B)\nvii\nResulting situation on the date on which threshold was crossed or reached\n17.15%\n17.15%\nPosition of previous notification (if\napplicable)\n16.04%\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\nviii\nA: Voting rights attached to shares\nClass/type ofshares\nISIN code (if possible)\nNumber of voting rights\nix\n% of voting rights\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nDirect\n(DTR5.1)\nIndirect\n(DTR5.2.1)\nGB00B1VKB244\n175,738,912\n17.15%\nSUBTOTAL 8. A\nB 1: Financial Instruments according to DTR5.3.1R (1) (a)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nNumber of voting rights that may be acquired if the instrument is\nexercised/converted.\n% of voting rights\nSUBTOTAL 8. B 1\nB 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)\nType of financial instrument\nExpirationdate\nx\nExercise/Conversion Period\nxi\nPhysical or cash\nSettlement\nxii\nNumber of voting rights\n% of voting rights\nSUBTOTAL 8.B.2\n9. Information in relation to the person subject to the notification obligation\n(please mark the\napplicable box with an \"X\")\nPerson subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer\nxiii\nFull\nchain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity\n(please add additional rows as necessary)\nxiv\nName\nxv\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\nDavid Nugent\n5.08%\n5.08%\nNugent (SW) Limited\n12.07%\n12.07%\n10.\nIn case of proxy voting, please identify:\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional information\nxvi\nPlace of completion\nDate of completion\n27-01-2026\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLFLFVVLAIDFIR",
          "rns_number": "RNS Number : 5901Q"
        },
        {
          "title": "Proposed equity raise of up to \u00a36.0 million",
          "date": "19th Jan 2026",
          "announcement_date": "19th Jan 2026",
          "release_time": "3:01 pm",
          "source": "RNS",
          "content": "19 Jan 2026 15:01\nRNS Number : 4805P\nGenedrive PLC\n19 January 2026\nTHIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR IN OR INTO ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW OR REGULATION.\nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF REGULATION (EU) NO 596/2014 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL OF 16 APRIL 2014 ON MARKET ABUSE (MARKET ABUSE REGULATION) AS RETAINED AS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 AS AMENDED.\nUPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.\ngenedrive plc\n(\"genedrive\" or the \"Company\")\nSignificant indicated support from two major shareholders for an equity raise of up to \u00a36.0 million\ngenedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, is pleased to announce that further to the announcement of 9 December 2025 confirming the terms of a Loan Agreement with the Company's largest shareholder, David Nugent, the Company is today announcing that David Nugent and Robert English, a significant shareholder in the Company, have informed the Company that they intend to subscribe for \u00a31.5m each (\u00a33m in total) in new equity as part of a broader equity financing of up to \u00a36.0m to fund the Company's various growth initiatives (the \"Equity Raise\").\nThe precise terms and structure of the Equity Raise are to be finalised as soon as possible however the Company intends to include an open offer to existing qualifying shareholders of up to \u00a32m (excess applications to be accepted and in which neither Mr Nugent nor Mr English would participate ahead of other shareholders) and an institutional placing. Further, Mr Nugent and Mr English have indicated that they are willing to subscribe for a proportion of the \u00a33m utilising the Company's existing share authorities which would provide a near-term extension to its current cash runway, with shareholder approval expected to be sought for the remainder of the Equity Raise. Finally, the Directors of the Company would intend to invest not less than \u00a3100,000 in the Equity Raise.\nMr. Nugent also intends to convert the \u00a3500,000 loan provided to the Company last month into new equity at the issue price of the Equity Raise. Mr Nugent intends that his beneficial shareholding post the Equity Raise / loan conversion will remain at less than 30% of the Company's voting rights.\nThe net proceeds of the Equity Raise would be expected to be used as follows:\n\u00b7\nSupporting continued near-term commercialisation & market expansion activities in UK, Europe & Middle East region.\n\u00b7\nFDA 510(k) submission for CYP2C19 anticipated around June 2026, with a 3-4 month review period post submission.\n\u00b7\nManufacture scale-up and efficiencies.\n\u00b7\nUser-led on-market refinements to product usability features.\n\u00b7\nTranslation of IP to include laboratory platform CYP2C19 genotyping assay in addition to point of care.\nThe parties have indicated that they would be willing to proceed with the Equity Raise at, or around, the current share price (including higher) and may also amend the total amount to be raised to ensure that any Equity Raise minimises the level of dilution whilst also providing meaningful additional capital for the Company's future growth plans.\nDr Gino Miele, CEO of genedrive plc, said:\n\"We very much welcome this indicated support from both David and Robert who are very aligned with the Board's view of the significant growth opportunities ahead for genedrive. Having two major shareholders indicating significant support for this equity financing and sharing our excitement about the future growth prospects and opportunities is a significant and positive development for the Company's financing plans.\"\nFor further details please contact:\ngenedrive plc\n+44 (0)161 989 0245\nGino Miele: CEO / Russ Shaw: CFO\nPeel Hunt LLP (Nominated Adviser and Broker)\n+44 (0)20 7418 8900\nJames Steel / Sohail Akbar (ECM)\nWalbrook PR Ltd (Media & Investor Relations)\n+44 (0)20 7933 8780 or\ngenedrive@walbrookpr.com\nAnna Dunphy\n+44 (0)7876 741 001\nAbout genedrive plc (\nhttp://www.genedrive.com\n)\ngenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare. Pharmacogenetics informs on how your individual genetics impact a medicines ability to work for you. Therefore, by using pharmacogenetics, medicine choices can be personalised, made safer and more effective. The Company has launched its two flagship products, the Genedrive\u00ae MT-RNR1 ID Kit and the Genedrive\u00ae CYP2C19 ID Kit, both developed and validated in collaboration with NHS partners and deployed on its point of care thermocycler platform. Both tests are single-use disposable cartridges which are ambient temperature stable, circumventing the requirement for cold chain logistics. The Directors believe the Genedrive\u00ae MT-RNR1 ID Kit is a worlds-first and allows clinicians to make a decision on antibiotic use in neonatal intensive care units within 26 minutes, ensuring vital care is delivered, avoiding adverse effects potentially otherwise encountered and with no negative impact on the patient care pathway. Its CYP2C19 ID Kit which has no comparably positioned competitor currently allows clinicians to make a decision on the use of Clopidogrel in stroke patients in 70 minutes, ensuring that patients who are unlikely to benefit from or suffer adverse effects from Clopidogrel receive an alternative antiplatelet therapeutic in a timely manner, ultimately improving outcomes. Both tests have undergone review by the National Institute for Health and Care Clinical Excellence (\"NICE\") and have been recommended for use in the UK NHS. The Company has a clear commercial strategy focused on accelerating growth through maximising in-market sales, geographic and portfolio expansion and strategic M&A, and operates out of its facilities in Manchester.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nIOEKZGMMDLRGVZM",
          "rns_number": "RNS Number : 4805P"
        },
        {
          "title": "Result of AGM",
          "date": "31st Dec 2025",
          "announcement_date": "31st Dec 2025",
          "release_time": "11:44 am",
          "source": "RNS",
          "content": "31 Dec 2025 11:44\nRNS Number : 3308N\nGenedrive PLC\n31 December 2025\ngenedrive plc\n(\"genedrive\" or the \"Company\")\nResult of AGM\ngenedrive plc (AIM: GDR), the point of care pharmacogenetic testing company,\nannounces that at the Annual General Meeting, held today, all resolutions proposed were duly passed.\nFor information, details of the proxy voting are shown below:\nResolution\nVotes For\nVotes For(as % of votes cast)\nVotes Against\nVotes Against(as % of votes cast)\nVote Withheld\n1\n300,517,371\n96.3%\n11,462,340\n3.7%\n310,795\n2\n279,601,700\n92.5%\n22,748,568\n7.5%\n9,940,238\n3\n274,303,174\n87.9%\n37,630,181\n12.1%\n357,151\n4\n277,003,174\n88.9%\n34,426,121\n11.1%\n861,211\n5\n273,385,392\n87.6%\n38,602,300\n12.4%\n302,814\n6\n278,647,955\n91.2%\n26,907,325\n8.8%\n6,735,226\n7\n265,095,868\n85.1%\n46,474,234\n14.9%\n720,404\n8\n285,423,686\n93.4%\n20,077,227\n6.6%\n6,789,593\n9\n274,147,003\n89.8%\n31,020,884\n10.2%\n7,122,619\n10\n278,146,034\n91.4%\n26,267,600\n8.6%\n7,876,872\n11\n278,179,297\n91.4%\n26,234,367\n8.6%\n7,876,842\nThe full text of each of the resolutions is set out in the notice of Annual General Meeting, copies of which are available on the Company's website (\nwww.genedrive.com\n).\nEngage with the genedrive management team directly by asking questions, watching video\nsummaries and seeing what other shareholders have to say. Navigate to our Interactive Investor\nhub here:\nhttps://investors.genedrive.com/link/PZ3d7y\nFor further details please contact:\nGenedrive plc\nDr Gino Miele (CEO)\nRuss Shaw (CFO)\nWe encourage all investors to share questions\non this announcement via our investor hub\nhttps://investors.genedrive.com/s/e0025c\n+44 (0) 161 989 0245\nPeel Hunt LLP - Nominated Adviser, Joint Broker\nJames Steel\n+44 (0) 20 7148 8900\nWalbrook PR Ltd (Media & Investor Relations)\nAnna Dunphy\nhttps://investors.genedrive.com/s/e0025c\n+44 (0)20 7933 8780 or\ngenedrive@walbrookpr.com\n+44 (0)7876 741 001\nSubscribe to our news alert service:\nhttps://investors.genedrive.com/s/efea03\nAbout genedrive plc\n(\nhttp://www.genedrive.com\n)\ngenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare. Pharmacogenetics informs on how your individual genetics impact a medicines ability to work for you. Therefore, by using pharmacogenetics, medicine choices can be personalised, made safer and more effective. The Company has launched its two flagship products, the Genedrive\u00ae MT-RNR1 ID Kit and the Genedrive\u00ae CYP2C19 ID Kit, both developed and validated in collaboration with NHS partners and deployed on its point of care thermocycler platform. Both tests are single-use disposable cartridges which are ambient temperature stable, circumventing the requirement for cold chain logistics. The Directors believe the Genedrive\u00ae MT-RNR1 ID Kit is a worlds-first and allows clinicians to make a decision on antibiotic use in neonatal intensive care units within 26 minutes, ensuring vital care is delivered, avoiding adverse effects potentially otherwise encountered and with no negative impact on the patient care pathway. Its CYP2C19 ID Kit which has no comparably positioned competitor currently allows clinicians to make a decision on the use of Clopidogrel in stroke patients in 70 minutes, ensuring that patients who are unlikely to benefit from or suffer adverse effects from Clopidogrel receive an alternative antiplatelet therapeutic in a timely manner, ultimately improving outcomes. Both tests have undergone review by the National Institute for Health and Care Clinical Excellence (\"NICE\") and have been recommended for use in the UK NHS. The Company has a clear commercial strategy focused on accelerating growth through maximising in-market sales, geographic and portfolio expansion and strategic M&A, and operates out of its facilities in Manchester.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nRAGBBBDDGSXDGUB",
          "rns_number": "RNS Number : 3308N"
        },
        {
          "title": "Scotland NHS \u201ctest of change\u201d pilot programme",
          "date": "18th Dec 2025",
          "announcement_date": "18th Dec 2025",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "18 Dec 2025 07:00\nRNS Number : 0225M\nGenedrive PLC\n18 December 2025\ngenedrive plc\n(\"genedrive\" or the \"Company\")\nGenedrive's CYP2C19 ID kit piloted as a \"test of change\" in Scotland NHS Grampian and Western Isles\ngenedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, announces that Genedrive's CYP2C19 ID Kit has been implemented into Scottish NHS Grampian (Dr. Gray's Hospital, Elgin) & NHS Western Isles (Western Isles Hospital, Stornoway) under a \"test of change\" pilot programme for stroke patients in remote and rural settings.\nWhilst the pathway for CYP2C19 genotyping in NHS Scotland currently relies on laboratory testing, the Centre For Sustainable Delivery, commissioned by the Scottish Government, are assessing the impact of rapid genetic testing using the Genedrive CYP2C19 ID kit under a \"test of change\" programme which will run for approximately one year and include c.400 patients.\nFurther details are available at\nhttps://shorturl.at/P4i00\nDr Gino Miele, CEO of genedrive plc, said:\n\"We are delighted that the Centre for Sustainable Delivery is assessing the impact of our interventional rapid genetic test solution in NHS Grampian and Western Isles, enabling a precision medicine approach to antiplatelet therapy in these stroke patients in rural settings, and ultimately, significantly better outcomes for patients in these communities. Whilst a relatively small \"pilot\" programme, it is notable that our interventional test is being explored as a \"test of change\" and we are confident that the clinical value of our rapid testing solution will continue to be evident and the case for wider deployment in Scotland strengthened.\"\nNHS Grampian consultant in stroke/acute medicine and clinical lead for the project, Petrus Elofuke, said:\n\"\nWe are introducing the Genedrive\u00ae CYP2C19 ID Kit test as a test of change in Elgin and Stornoway at the same time as samples are sent for lab-based testing. We'll look at how results compare over the next year. It's the first time a device of this kind has been tested in remote and rural settings, and we're extremely proud to be working with colleagues across the two health boards as well as the national Centre for Sustainable Delivery.\"\nClinical lead for the project in NHS Western Isles, David Rigby said:\n\"If the devices deliver proven results over the next year, then our project will inform the business case for revolutionising stroke care for remote and rural patients across Scotland. The Genedrive\u00ae devices are the size of a small shoe box and are easily accommodated in smaller rural hospitals. We are very pleased to be working closely alongside manufacturers Genedrive Diagnostics Ltd and providing huge benefit to local patients as we make the case for wider use of this exciting new tech.\"\nJason White the Head of Innovation in the Accelerated National Innovation Adoption (ANIA) team which is part of the NHS National Centre for Sustainable Delivery, said:\n\"This project is a powerful example of how innovation can directly improve patient care, especially in remote and rural communities. By enabling rapid genetic testing at the point of care, we're helping clinicians make faster, more informed decisions about stroke treatment. It's about delivering the right care, in the right place, at the right time and we're proud to support this collaborative effort through the ANIA pathway.\"\nEngage with the genedrive management team directly by asking questions, watching video\nsummaries and seeing what other shareholders have to say. Navigate to our Interactive Investor\nhub here:\nhttps://investors.genedrive.com/link/PZ3d7y\nFor further information, please contact:\nGenedrive plc\nDr Gino Miele (CEO)\nRuss Shaw (CFO)\nWe encourage all investors to share questions\non this announcement via our investor hub\nhttps://investors.genedrive.com/s/e0025c\n+44 (0) 161 989 0245\nPeel Hunt LLP - Nominated Adviser, Joint Broker\nJames Steel\n+44 (0) 20 7148 8900\nWalbrook PR Ltd (Media & Investor Relations)\nAnna Dunphy\nhttps://investors.genedrive.com/s/e0025c\n+44 (0)20 7933 8780 or\ngenedrive@walbrookpr.com\n+44 (0)7876 741 001\nSubscribe to our news alert service:\nhttps://investors.genedrive.com/s/efea03\nAbout genedrive plc (http://www.genedrive.com)\ngenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare. Pharmacogenetics informs on how your individual genetics impact a medicines ability to work for you. Therefore, by using pharmacogenetics, medicine choices can be personalised, made safer and more effective. The Company has launched its two flagship products, the Genedrive\u00ae MT-RNR1 ID Kit and the Genedrive\u00ae CYP2C19 ID Kit, both developed and validated in collaboration with NHS partners and deployed on its point of care thermocycler platform. Both tests are single-use disposable cartridges which are ambient temperature stable, circumventing the requirement for cold chain logistics. The Directors believe the Genedrive\u00ae MT-RNR1 ID Kit is a worlds-first and allows clinicians to make a decision on antibiotic use in neonatal intensive care units within 26 minutes, ensuring vital care is delivered, avoiding adverse effects potentially otherwise encountered and with no negative impact on the patient care pathway. Its CYP2C19 ID Kit which has no comparably positioned competitor currently allows clinicians to make a decision on the use of Clopidogrel in stroke patients in 70 minutes, ensuring that patients who are unlikely to benefit from or suffer adverse effects from Clopidogrel receive an alternative antiplatelet therapeutic in a timely manner, ultimately improving outcomes. Both tests have undergone review by the National Institute for Health and Care Clinical Excellence (\"NICE\") and have been recommended for use in the UK NHS. The Company has a clear commercial strategy focused on accelerating growth through maximising in-market sales, geographic and portfolio expansion and strategic M&A, and operates out of its facilities in Manchester.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nMSCEANAXFDPSFFA",
          "rns_number": "RNS Number : 0225M"
        },
        {
          "title": "New interactive investor hub",
          "date": "11th Dec 2025",
          "announcement_date": "11th Dec 2025",
          "release_time": "9:00 am",
          "source": "RNS",
          "content": "11 Dec 2025 09:00\nRNS Number : 1846L\nGenedrive PLC\n11 December 2025\ngenedrive plc\n(\"genedrive\" or the \"Company\")\ngenedrive plc launches new interactive investor hub\ngenedrive plc (LSE: GDR), the point of care pharmacogenetic testing company, is pleased to announce the launch of our interactive investor hub. For both existing and prospective shareholders, over time the new investor hub will bring all genedrive content into a single integrated platform to better inform and engage with investors and stakeholders.\nThe investor hub provides an interactive online experience allowing genedrive stakeholders to comment on and ask the genedrive team questions via a portal which will be monitored and responded to as timely as possible.\nHow to sign up for the genedrive investor hub:\n1. Visit\ninvestors.genedrive.com\n2. Follow the prompts to sign up for an investor hub account\n3. Complete your account profile\nDr Gino Miele, CEO of genedrive plc, said:\n\"Open and transparent communication with our shareholders is essential, particularly in a fast-moving environment like ours. Whilst RNS remains the first source of regulated news on genedrive, the investor hub gives us a direct channel to share accurate information and meaningful updates straight from the company ensuring investors hear from us directly. The hub enables shareholders to submit questions, receive updates, and engage directly with the Company. We encourage all investors to register and use the hub as their central source for trusted updates, insights, and dialogue with our team.\"\nEngage with the genedrive management team directly by asking questions, watching video\nsummaries and seeing what other shareholders have to say. Navigate to our Interactive Investor\nhub here:\nhttps://investors.genedrive.com/link/PZ3d7y\nFor further information, please contact:\nGenedrive plc\nDr Gino Miele (CEO)\nRuss Shaw (CFO)\nWe encourage all investors to share questions\non this announcement via our investor hub\nhttps://investors.genedrive.com/s/e0025c\n+44 (0) 161 989 0245\nPeel Hunt LLP - Nominated Adviser, Joint Broker\nJames Steel\n+44 (0) 20 7148 8900\nWalbrook PR Ltd (Media & Investor Relations)\nAnna Dunphy\nhttps://investors.genedrive.com/s/e0025c\n+44 (0)20 7933 8780 or\ngenedrive@walbrookpr.com\n+44 (0)7876 741 001\nSubscribe to our news alert service:\nhttps://investors.genedrive.com/s/efea03\nAbout genedrive plc (\nhttp://www.genedrive.com\n)\ngenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare. Pharmacogenetics informs on how your individual genetics impact a medicines ability to work for you. Therefore, by using pharmacogenetics, medicine choices can be personalised, made safer and more effective. The Company has launched its two flagship products, the Genedrive\u00ae MT-RNR1 ID Kit and the Genedrive\u00ae CYP2C19 ID Kit, both developed and validated in collaboration with NHS partners and deployed on its point of care thermocycler platform. Both tests are single-use disposable cartridges which are ambient temperature stable, circumventing the requirement for cold chain logistics. The Directors believe the Genedrive\u00ae MT-RNR1 ID Kit is a worlds-first and allows clinicians to make a decision on antibiotic use in neonatal intensive care units within 26 minutes, ensuring vital care is delivered, avoiding adverse effects potentially otherwise encountered and with no negative impact on the patient care pathway. Its CYP2C19 ID Kit which has no comparably positioned competitor currently allows clinicians to make a decision on the use of Clopidogrel in stroke patients in 70 minutes, ensuring that patients who are unlikely to benefit from or suffer adverse effects from Clopidogrel receive an alternative antiplatelet therapeutic in a timely manner, ultimately improving outcomes. Both tests have undergone review by the National Institute for Health and Care Clinical Excellence (\"NICE\") and have been recommended for use in the UK NHS. The Company has a clear commercial strategy focused on accelerating growth through maximising in-market sales, geographic and portfolio expansion and strategic M&A, and operates out of its facilities in Manchester.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nMSCUAUWRVBUUARA",
          "rns_number": "RNS Number : 1846L"
        }
      ],
      "themes": [
        "funding",
        "operations"
      ]
    },
    "social": {
      "has_data": true,
      "buzz_level": "HIGH",
      "post_count": 480,
      "sentiment_breakdown": {
        "positive": 0.0,
        "neutral": 100.0,
        "negative": 0.0
      }
    },
    "trends": {
      "has_data": true,
      "current_interest": 0,
      "momentum_score": 0,
      "trend_direction": "flat",
      "intelligence_signal": "UPTREND"
    },
    "volatility": {
      "atr_normalized": 7.9,
      "stddev_20d": 0.0
    },
    "risk_flags": {
      "split_risk_level": "NONE",
      "halt_risk": "NONE",
      "penny_stock_risk": "NONE"
    },
    "catalyst_dates": {
      "proxy_date": "2026-01-20"
    }
  },
  "ai_insights": {
    "company_30s": {
      "what_they_do": "GDR.L is a micro\u2011cap listed on AIM that appears to operate in the healthcare technology space, focusing on genetic testing solutions for the NHS.",
      "why_they_matter": "If the company can deliver its CYP2C19 genotype testing kit to NHS pilots, it could tap into a multi\u2011billion\u2011pound market for personalised medicine.",
      "current_state": "The firm is pre\u2011revenue, has been circulating a proposed equity raise, and is struggling to generate public interest or clear financial results."
    },
    "whats_happening_now": {
      "rns_narrative": [
        "Listing events: The company has filed multiple AIM admission and AGM result announcements over the past year, keeping its listing status in limbo and signalling a prolonged period of low public visibility.",
        "Fundraising: A proposed equity raise of up to \u00a36.0 million was announced in January 2026, indicating a need for fresh capital to fund product development and a potential NHS roll\u2011out.",
        "Results & NHS pilot: The latest RNS report covers NHS pilot programme updates, the company\u2019s most recent financial results, and a shareholder loan agreement, but no revenue figures are disclosed, leaving the financial picture opaque."
      ],
      "crowd_tape": {
        "dominant_theme": "The community remains largely silent; there is no measurable chatter on ShareChat or other platforms, and the sentiment is effectively neutral.",
        "bull_narrative": "Bullish voices, if any, point to the NHS pilot as a potential catalyst that could unlock a revenue stream and justify a future equity placement.",
        "bear_narrative": "Bears highlight the lack of revenue, the high dilution risk from a potential equity placement, and the absence of any clear product launch, warning that the stock may continue to languish.",
        "sentiment_shift": "There has been no observable shift; sentiment has stayed flat since the last filing, with no spikes in discussion or sudden optimism."
      },
      "attention_check": "Google Trends shows a flat line at 0/100 interest, and social media volume is zero. The story has lost oxygen\u2014no new searches, no posts, and no buzz to sustain investor curiosity. The lack of attention suggests that the market has moved on to other stories."
    },
    "expect_next": {
      "near_term_catalysts": [
        "NHS pilot results (Q1 2026): A positive outcome from the NHS CYP2C19 pilot could validate the product\u2019s market fit and open the door to a larger NHS contract."
      ],
      "watch_for": "Watch for any mention of revenue generation from the NHS pilot, director or shareholder selling, the outcome of the AGM vote on the shareholder loan, and the timing of the equity placement. A clear positive update could tilt the narrative in favour of a short\u2011term rally.",
      "timing_regime": "APEX classifies this setup as 'Exhausted'\u2014the company has been in a low\u2011activity phase for over a year, so the window for a meaningful entry is narrow and any catalyst must be strong to justify a move.",
      "recent_past_catalysts": [
        "Upcoming AGM (Dec 2025): The company will vote on the shareholder loan and any potential dilution, which could be a turning point for the stock and may determine whether the equity raise proceeds.",
        "Potential equity placement (Jan 2026): If the proposed \u00a36m raise materialises, it could provide the capital needed for product development, NHS roll\u2011out, and a short\u2011term price lift if priced below market."
      ]
    },
    "buy_vs_sell": {
      "lean": "Bearish",
      "bull_case": "If the NHS pilot proves successful and the company can convert that into a revenue stream, a short\u2011term spike could occur. This would require a clear positive update from the NHS and a successful equity placement that brings capital into the company, allowing it to move from a pre\u2011revenue to a product\u2011ready stage.",
      "bear_case": "The lack of revenue, flat market interest, and the looming risk of dilution from the equity raise make the stock a high\u2011risk play. Without a tangible product launch or a revenue surprise, the price is unlikely to recover from its 91.5% drop and could continue to slide towards the zero\u2011pence floor.",
      "risk_reward": "Low risk/reward profile\u2014potential upside is limited, while downside is virtually guaranteed if the story fails to ignite."
    },
    "playbook": {
      "if_bullish": "Enter only on a clear revenue announcement from the NHS pilot and a successful equity placement that brings capital into the company. Keep the position small (2\u20113% of the portfolio) and set a stop at the current price to limit losses.",
      "if_watching": "Wait for the AGM outcome and any sign of revenue generation. If the AGM resolves favourably and the company confirms a revenue trajectory, consider adding on a dip, but remain cautious until the next quarterly results.",
      "if_passing": "Stay out. The story is dormant, the company lacks traction, and the risk of dilution outweighs any speculative upside. Better setups elsewhere will offer higher probability of return."
    },
    "bottom_line": "Pass\u2014no momentum, no clear catalyst, and high dilution risk. The stock is a speculative, low\u2011reward play that is unlikely to deliver a meaningful return in the near term.",
    "_selected_rns": [
      {
        "title": "Holding(s) in Company",
        "date": "2026-01-27T00:00:00",
        "importance_score": 0.6613924050632911,
        "time_bucket": "NEAR",
        "rns_number": ""
      },
      {
        "title": "Proposed equity raise of up to \u00a36.0 million",
        "date": "2026-01-19T00:00:00",
        "importance_score": 0.640506329113924,
        "time_bucket": "NEAR",
        "rns_number": ""
      },
      {
        "title": "Result of AGM",
        "date": "2025-12-31T00:00:00",
        "importance_score": 0.561040787623066,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Final Results",
        "date": "2025-12-05T00:00:00",
        "importance_score": 0.3703435804701627,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Notice of Results",
        "date": "2025-12-03T00:00:00",
        "importance_score": 0.31293952180028123,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Scotland NHS \u201ctest of change\u201d pilot programme",
        "date": "2025-12-18T00:00:00",
        "importance_score": 0.30696202531645567,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Results presented re. NHS CYP2C19 Genotype Testing",
        "date": "2025-12-01T00:00:00",
        "importance_score": 0.3063291139240506,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "New interactive investor hub",
        "date": "2025-12-11T00:00:00",
        "importance_score": 0.24493670886075952,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Agreement of Shareholder Loan",
        "date": "2025-12-09T00:00:00",
        "importance_score": 0.2272151898734177,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "NHS implementation guide published for CYP2C19",
        "date": "2025-11-27T00:00:00",
        "importance_score": 0.17088607594936706,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Scotland national roll-out of MT-RNR1 ID Kit",
        "date": "2025-11-26T00:00:00",
        "importance_score": 0.1620253164556962,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Block Listing Returns",
        "date": "2025-12-01T00:00:00",
        "importance_score": 0.15632911392405063,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Further re Shareholder Loan",
        "date": "2025-11-19T00:00:00",
        "importance_score": 0.05,
        "time_bucket": "MID",
        "rns_number": ""
      }
    ]
  },
  "crashdash": {
    "industry_intelligence": {
      "category": "BIOTECH_PHARMA",
      "name": "Biotech & Pharma",
      "icon": "\ud83e\uddec",
      "color": "#10b981",
      "crash_patterns": [
        "Clinical trial failures (Phase 1/2/3)",
        "FDA/EMA rejection or delay",
        "Safety concerns or adverse events",
        "Patent expiry or IP challenges",
        "Funding gaps (cash runway concerns)"
      ],
      "recovery_paths": [
        "Positive trial data (efficacy endpoints met)",
        "Regulatory approvals (FDA/EMA)",
        "Partnership deals (big pharma licensing)",
        "Orphan drug designation or fast track",
        "New trial initiations (pipeline expansion)"
      ],
      "active_patterns": [
        "FDA/EMA rejection or delay",
        "Safety concerns or adverse events",
        "Patent expiry or IP challenges"
      ],
      "relevant_rns_count": 0,
      "key_metrics": [
        "Clinical stage (preclinical, Phase 1/2/3, commercialized)",
        "Cash runway (months until next funding)",
        "Addressable market size (indication)",
        "Trial enrollment progress",
        "Intellectual property strength"
      ]
    },
    "panic_analysis": {
      "panic_score": 59.2,
      "signal": "MODERATE_FEAR",
      "interpretation": "\ud83d\udfe1 Cautious sentiment - assess risk/reward",
      "breakdown": {
        "price_destruction": 37.2,
        "volume_death": 6,
        "social_silence": 6,
        "news_sentiment": 10
      },
      "is_opportunity": false,
      "opportunity_reason": "\ud83d\udcca Moderate fear detected - monitor for escalation"
    },
    "fear_vs_facts": {
      "fear_points": [
        "\ud83d\udc94 Price destruction: 37/40 points"
      ],
      "facts_points": [
        "\ud83d\udcc8 Historical upside: 361% proven capacity"
      ],
      "verdict": "\u2696\ufe0f Mixed signals - Fear and facts balanced, wait for clarity"
    },
    "crashhunter_signals": [
      {
        "type": "CROWDED",
        "icon": "\u26a0\ufe0f",
        "text": "Crowded",
        "color": "#f59e0b"
      },
      {
        "type": "MODERATE_QUALITY",
        "icon": "\ud83c\udf1f",
        "text": "APEX 53",
        "color": "#3b82f6"
      }
    ],
    "catalyst_pipeline": [
      {
        "type": "rns",
        "date": "27th Jan 2026",
        "title": "Holding(s) in Company",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "19th Jan 2026",
        "title": "Proposed equity raise of up to \u00a36.0 million",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "31st Dec 2025",
        "title": "Result of AGM",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "18th Dec 2025",
        "title": "Scotland NHS \u201ctest of change\u201d pilot programme",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "11th Dec 2025",
        "title": "New interactive investor hub",
        "status": "published",
        "icon": "\ud83d\udce2"
      }
    ],
    "decision_matrix": {
      "decision": "AVOID",
      "reason": "\u274c SELL/TAKE_PROFITS - timing CROWDED",
      "checklist": [
        {
          "criterion": "Panic Score",
          "value": "59/100",
          "pass": false,
          "icon": "\ud83d\udfe2"
        },
        {
          "criterion": "Timing Regime",
          "value": "CROWDED",
          "pass": false,
          "icon": "\u2705"
        },
        {
          "criterion": "APEX Quality",
          "value": "53/100",
          "pass": true,
          "icon": "\u2b50"
        },
        {
          "criterion": "Data Confidence",
          "value": "40/100",
          "pass": true,
          "icon": "\ud83c\udfaf"
        },
        {
          "criterion": "Industry Pattern",
          "value": "3 active",
          "pass": true,
          "icon": "\ud83e\uddec"
        }
      ],
      "pass_rate": "3/5"
    },
    "contrarian_panic": {
      "total_score": 35,
      "band": "\ud83d\udfe2 MILD COMPRESSION (Top 50% - WATCHLIST)",
      "components": {
        "compression": {
          "score": 19,
          "max": 40,
          "signals_30d": 6,
          "signals_60d": 7,
          "signals_90d": 7,
          "signals_per_week": 0.54,
          "total_signals": 63,
          "rsi_extreme_count": 2,
          "rsi_ultra_count": 2,
          "escalation_count": 1,
          "density_score": 8,
          "rsi_score": 4,
          "escalation_score": 4,
          "description": "0.5 signals/week | 2 RSI<20 | 1 escalations | \ud83d\udcca MODERATE COMPRESSION"
        },
        "intensification": {
          "score": 5,
          "max": 20,
          "recent_types": [
            "DEEP CRASH BOTTOM",
            "DEEP CRASH BOTTOM",
            "DEEP CRASH BOTTOM"
          ],
          "escalating": false,
          "sustained": false,
          "current_intensity": 2,
          "pattern": "NORMAL CRASH LEVEL"
        },
        "volume_death": {
          "score": 0,
          "max": 15,
          "relative_volume": 1.5,
          "description": "Normal volume"
        },
        "pop_potential": {
          "score": 11,
          "max": 15,
          "best_historical_rally": 410.9,
          "avg_rally": 177.5,
          "signal_count": 63,
          "description": "SOLID MOVER - Historical 3x+ (411%)"
        },
        "accumulation": {
          "score": 0,
          "max": 10,
          "has_accumulation": false,
          "bars_since_accum": 0,
          "description": "No accumulation"
        }
      },
      "ticker": "GDR.L",
      "signal_date": "2025-10-07",
      "total_signals_history": 63
    }
  },
  "scoring_breakdown": {
    "apex_factors": [
      "Technical quality: +12 (AI_Technical_Score=10.0/20)",
      "Drawdown reversion potential: +18 (Drawdown_Pct=91.5%)",
      "Volume confirmation: +6 (Relative_Volume=1.5)",
      "Pattern reliability: +5 (Rally_Count=1.0)",
      "Upside history: +12 (best_rally_pct=361%)"
    ],
    "technical_score": {
      "points": 12,
      "ai_score": 10.0,
      "reason": "AI Technical Score 10.0/20 translates to 12/25 points"
    },
    "drawdown_score": {
      "points": 18,
      "drawdown_pct": 91.5,
      "reason": "Drawdown of 91.5% gives 18/20 points"
    },
    "volume_score": {
      "points": 6,
      "rel_volume": 1.5,
      "reason": "Relative volume 1.50x gives 6 points"
    },
    "pattern_score": {
      "points": 5,
      "rally_count": 1.0,
      "reason": "1.0 historical rallies gives 5/15 points"
    },
    "upside_score": {
      "points": 12,
      "best_rally_pct": 360.78,
      "reason": "Best rally of 361% gives 12/20 points"
    },
    "penalties": {
      "total": 0,
      "items": []
    }
  },
  "reasons_buy_sell": {
    "reasons_to_buy": [
      {
        "reason": "Proven winner - previously hit lock-in target",
        "tag": "MED",
        "evidence": [
          "lock_in_reached=True"
        ]
      }
    ],
    "reasons_to_sell": [
      {
        "reason": "Stale signal - not for active trading",
        "tag": "HIGH",
        "evidence": [
          "status=historical",
          "signal_date=2025-10-07"
        ]
      }
    ]
  },
  "trade_plan": {
    "trader_plan": {
      "style": "Active trade",
      "action": "SELL/TAKE_PROFITS",
      "sizing": "1-3% position based on conviction",
      "risk": "Stop below recent support / invalidation level",
      "profit_taking": "Scale out into strength: 25% @ +15%, 50% @ +50%, trail runner"
    },
    "investor_plan": {
      "allowed": false,
      "thesis_conditions": "Unlock after AI triangulation + CONFIRMED timing",
      "hold_window": "N/A",
      "risk_management": "N/A"
    }
  },
  "exhaustion": {
    "regime": "CROWDED",
    "run_multiple": 0.9,
    "current_run_pct": 325.1,
    "avg_historical_run_pct": 360.78
  },
  "history_snapshot": {
    "previous_report_date": null,
    "score_change": null,
    "confidence_change": null,
    "new_events_count": 0,
    "new_rns_titles": []
  },
  "commentary": {
    "executive_summary": "Note: this report used historical signals only \u2014 live triangulation (RNS, social, Trends) was not available. Current setup looks like CROWDED with an APEX score of 53/100. Historically there have been 1 rallies (avg. 361%); the position is now +325.1%. Practical take: this is interesting but unconfirmed \u2014 wait for an AI snapshot or clear confirmation before committing size.",
    "bull_case": [
      "No obvious upside without a catalyst"
    ],
    "bear_case": [
      "No immediate red flags, but keep stops tight"
    ],
    "timing_translation": "Late-stage rally \u2014 trim into strength and tighten risk.",
    "confidence_explained": "Confidence 40/100 \u2014 data triangulated from RNS, social and Trends."
  },
  "data_quality": {
    "sources_present": {
      "snapshot_json": false,
      "daily_enrichment_row": true,
      "historical_profile": true,
      "metadata": true,
      "triangulation_events": true,
      "ai_insights": true
    },
    "missing_data": [
      "AI insights from Groq LLM"
    ],
    "confidence_impact": "HIGH",
    "disclaimer": "Data provided as-is. Not financial advice. AIM micro-caps carry significant volatility risk."
  }
}